31 October 2023
Notice of Annual General Meeting
Atlantic Lithium Limited (AIM: ALL, ASX: A11, OTCQX: ALLIF, "Atlantic Lithium" or the "Company"), the African-focused lithium exploration and development company targeting to deliver Ghana's first lithium mine, announces that its Annual General Meeting ("AGM") will be held at the offices of HopgoodGanim Lawyers, Allendale Square, Level 27, 77 St Georges Terrace, Perth WA 6000 at 2pm (Perth time) on 30 November 2023.
The AGM materials will be despatched to shareholders today and can be viewed via the link below:
http://www.rns-pdf.londonstockexchange.com/rns/7943R_1-2023-10-31.pdf
A copy of the AGM materials can also be found on the Company's website https://www.atlanticlithium.com.au/gm-notices.
FOR ANY FURTHER INFORMATION, PLEASE CONTACT:
ATLANTIC LITHIUM LIMITED
Neil Herbert (Executive Chairman)
Amanda Harsas (Finance Director and Company Secretary)
|
| www.atlanticlithium.com.au | ||
|
| IR@atlanticlithium.com.au | ||
|
| Tel: +61 2 8072 0640
| ||
|
SP Angel Corporate Finance LLP Nominated Adviser Jeff Keating Charlie Bouverat Tel: +44 (0)20 3470 0470 |
Yellow Jersey PR Limited Charles Goodwin Bessie Elliot Tel: +44 (0)20 3004 9512
|
Canaccord Genuity Limited Company Broker Raj Khatri / James Asensio Harry Rees Tel: +44 (0) 20 7523 4500 | |
NOTES TO EDITORS:
About Atlantic Lithium
Atlantic Lithium is an AIM and ASX-listed lithium company advancing a portfolio of lithium projects in Ghana and Côte d'Ivoire through to production.
The Company's flagship project, the Ewoyaa Project in Ghana, is a significant lithium spodumene pegmatite discovery on track to become Ghana's first lithium-producing mine. The Company signed a funding agreement with Piedmont Lithium Inc. towards the development of the Project. At the Ewoyaa Project, Atlantic Lithium intends to be producing spodumene concentrate via a simple gravity only process flowsheet.
Atlantic Lithium holds 560km2 and 774km2 of tenure across Ghana and Côte d'Ivoire respectively, comprising significantly under-explored, highly prospective licences.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.